FDA Inspection 1070291 — Livzon Group (Ningxia) Pharmaceutical Co., Ltd.
The FDA completed an inspection of Livzon Group (Ningxia) Pharmaceutical Co., Ltd. on October 19, 2018 in Shizuishan. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- October 19, 2018
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Shizuishan (China)